CPT code 87624: High-risk HPV, pooled result2026 Medicare lab fee · Clinical Laboratory Fee Schedule
A nucleic-acid test detects high-risk human papillomavirus as a pooled result, commonly for cervical cancer screening or evaluation of abnormal cervical findings.
Medicare pays $35.09 for 87624 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$35.09
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 87624 covers
This molecular test detects high-risk human papillomavirus (HPV) nucleic acid and reports a pooled result rather than identifying each detected type separately. It is commonly performed on a cervical-cell specimen in screening, evaluation of abnormal cervical cytology, or follow-up of cervical abnormalities. Laboratories perform the assay, with clinicians ordering it as part of cervical cancer screening or assessment. The pooled result indicates whether high-risk HPV was detected, not which individual type was present.
Report one service for the pooled high-risk HPV test performed on the specimen; the code does not describe separate genotype results. The 2026 national CLFS amount is $35.09, unchanged since 2020. Medicare pays this code from the CLFS at one national amount in every locality, with no office or facility difference. The test is excluded from the physician fee schedule and is paid only through the CLFS.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 87624
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 87624. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 87624 with status X (excluded by statute), so the test itself is paid only from the CLFS.
87624 on the lab fee schedule since 2020
87624 · CLFS 2026 Q4 (current)
$35.09
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
87624 compared with similar tests
- 87623Low-risk HPVNucleic acid detection$35.09
- 87623 is for low-risk HPV types. Choose 87624 for a pooled result covering high-risk types.
- 87625HPV genotypingTypes 16 and 18$40.55
- 87625 targets HPV types 16 and 18 specifically; 87624 reports a pooled high-risk HPV result.
- 87626HPV testSeparate types and pooled results$70.20
- 87626 reports selected high-risk types separately plus a pool for other types. Use 87624 when the reported result is pooled.
87624 billing questions
How does this differ from code 87625?
Code 87624 reports a pooled high-risk HPV result. Code 87625 is for testing specifically for HPV types 16 and 18.
When would code 87626 be more appropriate?
Use 87626 when the assay reports certain high-risk types separately along with a pooled result for other high-risk types. Code 87624 represents a pooled result.
Does this code identify the specific HPV type detected?
No. The result is pooled, so the code does not report which individual high-risk HPV type was detected.
How many units are reported for a pooled test?
Report one service for the pooled test performed on the specimen. The code does not represent a separate unit for each HPV type in the pool.
How does Medicare pay for this test?
Medicare pays it only through the CLFS, using one national amount across localities and without an office or facility difference. The test is excluded from the physician fee schedule.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets
Put 87624 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Build my fee sheet